Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 15,811 $ 32,190
Marketable securities, current   28,859
Prepaid expenses 2,999 3,459
Other current assets 3,890 3,790
Total current assets 22,700 68,298
Operating lease right-of-use assets 9,667 11,132
Property and equipment, net 8,578 14,632
Other assets 3,116 3,486
Total assets 44,061 97,548
Current liabilities:    
Accounts payable 2,583 504
Accrued liabilities 3,303 8,823
Deferred revenue, current 13,210 45,573
Other current liabilities 2,416 2,182
Total current liabilities 21,512 57,082
Deferred revenue, long-term   5,904
Long-term debt, net of current portion   36,168
Operating lease liabilities, long term portion 10,396 12,231
Contingent value right liability 3,975  
Other liabilities 1,377 1,295
Total liabilities 37,260 112,680
Commitments and contingencies (Note 10)
Stockholders' equity/(deficit)    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares as of September 30, 2023 and December 31, 2022; Issued and outstanding: 250 shares at September 30, 2023 and December 31, 2022
Common stock, $0.001 par value: Authorized: 150,000,000 shares as of September 30, 2023 and December 31, 2022; Issued and outstanding: 5,374,268 shares at September 30, 2023 and 3,756,711 shares at December 31, 2022 respectively [1] 5 4
Additional paid-in capital [1] 455,739 429,698
Accumulated other comprehensive income/(loss) 1 (66)
Accumulated deficit (448,944) (444,768)
Total stockholders' equity/(deficit) 6,801 (15,132)
Total liabilities and stockholders' equity/(deficit) $ 44,061 $ 97,548
[1] Prior period amounts have been retrospectively adjusted for the 1-for-15 reverse stock split that was effective August 11, 2023 (see Note 1).